Next Article in Journal
Change in Rotavirus Vaccine Coverage in Brazil from before (2015–2019) through the COVID-19 Pandemic Period (2020–2021)
Previous Article in Journal
Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS-CoV-2 Infection in an Immunocompromised Patient
 
 
Article
Peer-Review Record

Protein Arginylation Is Regulated during SARS-CoV-2 Infection

Viruses 2023, 15(2), 290; https://doi.org/10.3390/v15020290
by Janaina Macedo-da-Silva 1, Livia Rosa-Fernandes 1,2, Vinicius de Morais Gomes 1, Veronica Feijoli Santiago 1, Deivid Martins Santos 1, Catarina Maria Stanischesk Molnar 1, Bruno Rafael Barboza 1, Edmarcia Elisa de Souza 3, Rodolfo Ferreira Marques 4, Silvia Beatriz Boscardin 4, Edison Luiz Durigon 5, Claudio Romero Farias Marinho 2, Carsten Wrenger 3, Suely Kazue Nagahashi Marie 6 and Giuseppe Palmisano 1,7,*
Reviewer 2: Anonymous
Viruses 2023, 15(2), 290; https://doi.org/10.3390/v15020290
Submission received: 26 October 2022 / Revised: 9 January 2023 / Accepted: 17 January 2023 / Published: 19 January 2023
(This article belongs to the Section Human Virology and Viral Diseases)

Round 1

Reviewer 1 Report

Dear Editor,

Macedo-da-Silva et. al. have presented a comprehensive study on the role of protein arginylation during SARS-CoV-2 infection. Using various cell lines like Vero CCL-81, THP1, calu 3 cells , the authors examine protein arginylation profile of proteins as well as ATE1. They also show increased expression of ATE1 after SARS-CoV-2 infection demonstrating the importance of arginylation during infection.

 

The authors have presented the study in a detailed and clear manner. I do however have some comments on the data that perhaps the authors could address.

1.     Abstract: Spell check Vero CCL -81 cells.

2.     Figure 1D: Please indicate that that no statistical significance was observed.

3.     Figure 2: Which pathway do DUOX1, DUOX2 appear in 2A? Please indicate. Do the authors see differences in ATE1 mRNA level after infection in Calu-3 and Vero CCL-81 cells

4.     Figure 2 and 4, 7, 8: Do the authors always observe variability in GAPDH levels between samples? In Figure 4: Are the quantifications ( For eg: BIP-Arg/BIP) normalized to GAPDH?

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Remarks to the Author:

 

SARS-CoV-2 infection induces protein arginylation and modulation of the N-degron pathway by up-regulating ATE1, which is dominated by Spike protein. This phenomenon differs between different types of cells. The protein arginylation induced by viruses is not novel. No direct evidence of the protein being arginated was seen in the present study. Through this paper, the bioinformation results are clear and consistent with reported results. However, biochemical results are not good enough.

 

My major comments:

 

Fig 2B. It seems like no significantly increases of ATE1 expression after virus infection. The number of cells varies through GAPDH bands

 

Fig 4. The quality of WB should be improved. There is no discernible trend

 

Fig 5. Many papers reported that SARS-Cov2 can induce autophagy. These data cannot explain arginylated proteins target autophagy.

 

Fig 7. You’d better screen all viral proteins of SARS-Cov2 to identify the role of spike on the expression of ATE1.

 

Fig 8. What’s the protein level of SARS-CoV2? Detect the N or E expression after SARS-CoV2 infection treated by ATE1 inhibition.

 

Fig 10B. GAPDH level has the same trend with ATE1, R-BIP? Why?

Author Response

Please see attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

  • The revised article should be accepted

Back to TopTop